Freeline

PITCH

Freeline is a privately-held clinical-stage biotechnology company focused on AAV based gene therapy targeting the liver. Our vision is to create better lives for people suffering from chronic systemic diseases using the potential of gene therapy as a one-off curative treatment. Freeline has developed a next-generation AAV based gene therapy platform to provide treatments for a wide range of diseases like haemophilia B, Fabry and Gaucher Disease which have previously been underserved and incurable. We are headquartered in the UK and we also have operations in Germany and the US.

Based in

Stevenage

Created in

> Website

LATEST INVESTMENT

#biotech 07.2020

Freeline

£95.8M

Novo Holdings, Eventide Asset Management, Wellington Management Company, Cowen Healthcare Investments, Acorn Bioventures, Ample Plus Fund